Form 144 - Report of proposed sale of securities:
SEC Accession No. 0002007317-25-000023
Filing Date
2025-01-21
Accepted
2025-01-21 20:58:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2849
  Complete submission text file 0002007317-25-000023.txt   4300
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Subject) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38520 | Film No.: 25543692
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MEIRAGTX - US 430 EAST 29TH STREET, 10TH FLOOR NEW YORK NY 10016
Business Address
Giroux Richard (Reporting) CIK: 0001742734 (see all company filings)

Type: 144